Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.

Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Trigyn : More than meets the eye - Views on News from Equitymaster
  • E-MAIL
  • A  A  A
  • Nov 15, 2000

    Trigyn : More than meets the eye

    Trigyn Technologies (formerly Leading Edge) had projected a 100% growth in turnover to US$ 40 m for FY01. Till the first half of FY01 the company has achieved a turnover of US$18 m. The company seems well on track to achieve its target.

    Trigyn has added 22 new clients in the last quarter, out of which 10 are for the product eVector. As a result, the contribution of products to the revenue has increased and body shopping (euphemistically know as employee augmentation) is down to around 22%. The business mix too has changed slightly in favour of Telecom. In short, Trigyn is moving up the value chain.

    The company’s employee utilisation rate is around 85%. 60% of its employees are in to projects, 25% in product development, 7% are engaged in the training and the remaining 8% on the bench (waiting for assignments). This is comparable to its peers in the industry

    The company’s revenues from Europe and Asia Pacific markets are improving, the positive results of which, will reflect in the coming quarter. Also, the company claims that its e-business clients are shifting from dot coms to corporate.

    However, the above painted picture is very rosy. Let us look at the fine prints. For the second quarter there is a huge component of other income Rs 40 m in net profit (PAT). If you remove this component the company’s PAT has fallen (down 40%) compared to the previous quarter. The company explains that this other income is due to profits from forex fluctuations and the rest are earnings from interest. Last quarter this figure was just Rs 5 m.

    Also, the operating profit margins for the company is 21%. This is way below the industry benchmark of above 30%. The company claims that this is because of the losses on account of E Capital solution (a company Trigyn has acquired). Trigyn is writing off around US$ 500,000 on account of non-payment from a client (which it refused to name). This is unheard of in the industry (except for Mastek).

    Trigyn has made a tax provision at the rate of 33% this quarter. Considering all its businesses are from exports this tax provisioning seems strange. Trigyn’s sales recovery period is 105 days, which is higher than the industry average of 90 days.

    (Rs m) 1QFY01 2QFY01 Change
    Sales 201 238 18.5%
    Other Income 5 40 775.2%
    Expenditure 159 187 17.4%
    Operating Profit (EBDIT) 42 52 22.8%
    Operating Profit Margin (%) 20.9% 21.7%  
    Interest 1 2 40.4%
    Depreciation 6 7 15.9%
    Profit before Tax 40 84 110.2%
    Tax 5 27 480.9%
    Profit after Tax/(Loss) 35 57 60.7%
    Net profit margin (%) 17.5% 23.7%  
    No. of Shares (eoy) (m) 14.8 14.8  
    Diluted Earnings per share* 9.5 15.2  
    P/E (at current price) 46 28  

    To sum it up, increase in top line is easy as there is a severe dearth of solutions. But what matters the most and what will be critical to survival in the digital economy is the management.

    But what baffles industry watchers is the company’s declining contribution from financial services products, especially at a time when this is the fastest growing segment in the software industry. This is surprising as Trigyn has a good amount of experience in the financial services industry. With hardly any solutions provider in the securities segment Trigyn can benefit from the first mover advantage. But currently this doesn’t seem to be happening.

    Bottomline, caution is the buzzword, till the company comes out clean on all issues. Sustainability is not in grabbing opportunities but in delivering, profitably.



    Equitymaster requests your view! Post a comment on "Trigyn : More than meets the eye". Click here!


    More Views on News

    Tech Mahindra: Our Revised View (Quarterly Results Update - Detailed)

    Aug 2, 2017

    A better than expected turnaround in performance results in a change in view.

    Wipro: A Decent Start to the Year (Quarterly Results Update - Detailed)

    Jul 27, 2017

    Digital services drive growth for Wipro in 1QFY18.

    Infosys: A Decent Start to FY18 (Quarterly Results Update - Detailed)

    Jul 14, 2017

    Infosys starts FY18 on an encouraging note with a stable performance.

    TCS: Currency Volatility Plays Spoilsport (Quarterly Results Update - Detailed)

    Jul 14, 2017

    TCS starts FY18 decently despite an adverse currency impact.

    HCL Tech: Ends FY17 on Expected Lines (Quarterly Results Update - Detailed)

    Jun 29, 2017

    Volvo partnership caps a good year for HCL Technologies.

    More Views on News

    Most Popular

    Demonetisation Barely Made Any Difference to Tax Collections(Vivek Kaul's Diary)

    Aug 7, 2017

    The data tells us quite a different story from the one the government is trying to project.

    Proxy Plays: A Smart Way to Bet on 'Off Limits' Companies(The 5 Minute Wrapup)

    Aug 4, 2017

    The small-cap space is full of small players that are clear proxies to great growth stories and Indian megatrends.

    Should You Invest In Bharat-22 ETF? Know Here...(Outside View)

    Aug 8, 2017

    Bharat-22 is one of the most diverse ETFs offered so far by the Government. Know here if you should invest...

    Signs of Life in the India VIX(Daily Profit Hunter)

    Aug 12, 2017

    The India VIX is up 36% in the last week. Fear has gone up but is still low by historical standards.

    7 Financial Gifts For Your Sister This Raksha Bandhan(Outside View)

    Aug 7, 2017

    Raksha Bandhan signifies the brother-sister bond. Here are 7 thoughtful financial gifts for sisters...

    Copyright © Equitymaster Agora Research Private Limited. All rights reserved.
    Any act of copying, reproducing or distributing this newsletter whether wholly or in part, for any purpose without the permission of Equitymaster is strictly prohibited and shall be deemed to be copyright infringement.

    LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.

    SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.

    Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India.
    Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: info@equitymaster.com. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407

    Become A Smarter Investor In
    Just 5 Minutes

    Multibagger Stocks Guide 2017
    Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
    We will never sell or rent your email id.
    Please read our Terms


    Aug 17, 2017 02:58 PM


    • Track your investment in TRIGYN TECHNOLOGIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
    • Add To MyStocks